Tripti Rungta

Tripti Rungta

Auto-generated profile, based on publicly available information

Tripti Rungta

Department of Virology Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VCVarun Chauhan
Varun Chauhan
TRTripti Rungta
Tripti Rungta
KGKapil Goyal
Kapil Goyal
MSMini P. Singh
Mini P. Singh
Kaposi’s sarcoma-associated herpesvirus (KSHV) responsible for causing Kaposi sarcoma (KS), an opportunistic angioproliferative neoplasm is emerging rapidly. Despite this there is no permanent cure for this disease. The present study was aimed to design a multi-epitope based vaccine targeting the major glycoproteins of KSHV which plays an important role in the virus entry. After the application of rigorous immunoinformatics analysis and several immune filters, the multi-epitope vaccine was constructed, consisting of CD4, CD8 and IFN-γ inducing epitopes. Several physiochemical characteristics, allergenicity and antigenicity of the multi-epitope vaccine were analyzed in order to ensure its safety and immunogenicity. Further, the binding affinity and stability of the vaccine with Toll like receptor -9 (TLR-9) was analyzed by molecular docking and dynamics simulation studies. In addition, an in silico cloning was performed to ensure the expression and translation efficiency of the vaccine, utilizing pET-28a (+) vector. Such T-cell-based immunotherapies which leverage this mechanism could prove their potential against cancer. Further, the authors propose to test the present findings in the lab settings to ensure the safety, immunogenicity and efficacy of the presented vaccine which may help in controlling KSHV infection.

9 July 2020 in Journal of Cellular Physiology
Verified
Journal Article
Open access
PDF file
VCVarun Chauhan
Varun Chauhan
TRTripti Rungta
Tripti Rungta
Manmeet RawatManmeet Rawat
Manmeet Rawat
KGKapil Goyal
Kapil Goyal
Yash GuptaYash Gupta
Yash Gupta
MSMini P. Singh
Mini P. Singh
Since the outbreak of severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) in December 2019 in China, there has been an upsurge in the number of deaths and infected individuals throughout the world, thereby leading to the World Health Organization declaration of a pandemic. Since no specific therapy is currently available for the same, the present study was aimed to explore the SARS‐CoV‐2 genome for the identification of immunogenic regions using immunoinformatics approach. A series of computational tools were applied in a systematic way to identify the epitopes that could be utilized in vaccine development. The screened‐out epitopes were passed through several immune filters, such as promiscuousity, conservancy, antigenicity, nonallergenicity, population coverage, nonhomologous to human proteins, and affinity with human leukocyte antigen alleles, to screen out the best possible ones. Further, a construct comprising 11 CD4, 12 CD8, 3 B cell, and 3 interferon‐γ epitopes, along with an adjuvant β‐defensin, was designed in silico, resulting in the formation of a multiepitope vaccine. The in silico immune simulation and population coverage analysis of the vaccine sequence showed its capacity to elicit cellular, humoral, and innate immune cells and to cover up a worldwide population of more than 97%. Further, the interaction analysis of the vaccine construct with Toll‐like receptor 3 (immune receptor) was carried out by docking and dynamics simulations, revealing high affinity, constancy, and pliability between the two. The overall findings suggest that the vaccine may be highly effective, and is therefore required to be tested in the lab settings to evaluate its efficacy.

1 January 2018 in Indian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
MSMini P. Singh
Mini P. Singh
JRJagat Ram
Jagat Ram
AKArchit Kumar
Archit Kumar
TRTripti Rungta
Tripti Rungta
AGAmit Gupta
Amit Gupta
RRRadha Kanta Ratho
Radha Kanta Ratho
Human adenovirus (HAdV) is a major cause of viral conjunctivitis. The various serotypes implicated in the causation are 3, 4, 8, 19 and 37. The present study aimed to know the circulating types of HAdV causing acute conjunctivitis in North India. A total of 23 conjunctival swabs were collected from patients with clinically suspected acute viral conjunctivitis during 2014–2015. The HAdV was implicated in the etiology in 65.2% of cases. The sequencing of representative samples using hexon gene suggests the presence of serotype 8 and 4. The serotype eight sequences showed 99%–100% similarity with other Indian strains. The phylogenetic analysis showed that the current circulating serotypes, responsible for conjunctivitis, belonged to epidemic keratoconjunctivitis strains.

26 March 2018 in European Journal of Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
AKArchit Kumar
Archit Kumar
MSMini P. Singh
Mini P. Singh
TRTripti Rungta
Tripti Rungta
APAjay Patial
Ajay Patial
SASavvita Verma Attri
Savvita Verma Attri
RRRadha Kanta Ratho
Radha Kanta Ratho

1 January 2019 in Indian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
MSMini P. Singh
Mini P. Singh
TRTripti Rungta
Tripti Rungta
AKArchit Kumar
Archit Kumar
KGKapil Goyal
Kapil Goyal
BBBhavneet Bharti
Bhavneet Bharti
RRR.K. Ratho
R.K. Ratho
Introduction: Varicella outbreaks are known to occur in developing nations as vaccine coverage is still low. Material and Methods: In the present study, an institutional outbreak from Chandigarh, India, is reported wherein the utility of non-invasive samples such as saliva and urine was studied for the molecular diagnosis of varicella by conventional polymerase chain reaction (PCR), real-time PCR and real-time loop-mediated isothermal amplification (real-time LAMP). Results: The results of the present study showed that saliva and urine samples can be used for outbreak investigation of varicella compared to varicella-zoster virus DNA in vesicular swab samples with reasonable sensitivity. Conclusion: Thus, molecular techniques may be useful in the early identification of the outbreak and timely isolation, and the treatment of cases can further prevent its spread.